Patient demographics, diagnostic tumor size, number of tumors, tumor markers including CEA, SCC, CYFRA, proGRP, NSE, TPA, SLX, history of smoking (estimated by Pack-Year index), the presence of metastasis or recurrence, and clinical stage (IA~IV) were evaluated. Here, ENO2 is linked to neoplasm.